Ligand Pharmaceuticals Newsroom

Ligand Pharmaceuticals Price Target Raised to $110.00/Share From $95.00 by Benchmark

Dow JonesAug 13 01:03

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 13 00:29

RBC Capital Reiterates Outperform on Ligand Pharmaceuticals, Maintains $130 Price Target

BenzingaAug 13 00:29

Ligand Pharmaceuticals Price Target Maintained With a $144.00/Share by HC Wainwright & Co.

Dow JonesAug 8 19:00

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 8 01:17

RBC Capital Reiterates Outperform on Ligand Pharmaceuticals, Maintains $130 Price Target

BenzingaAug 8 01:14

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Futu NewsAug 6 21:32

Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $110

Futu NewsAug 6 18:31

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Futu NewsAug 5 21:33

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 30 18:06

RBC Capital Initiates Coverage On Ligand Pharmaceuticals With Outperform Rating, Announces Price Target of $130

BenzingaJul 30 18:05

RBC Capital Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $130

Futu NewsJul 30 17:34

Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $110

Futu NewsJul 25 17:31

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Futu NewsJul 24 21:36

Craig-Hallum Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $140

BenzingaJul 10 01:28

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaJul 9 01:59

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 9 01:57

What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals

BenzingaJun 29 03:02

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaJun 28 22:16

Ligand Pharmaceuticals Analyst Ratings

BenzingaJun 27 23:47